Selank 10 mg

Overview

Selank is a synthetic heptapeptide based on a tuftsin related sequence used as a tool compound in central nervous system and neuroimmune research.
It is applied in controlled preclinical models to study peptide driven modulation of molecular signaling networks gene expression and neurotransmission.
The summary below outlines common experimental applications of Selank in the literature. All observations are model specific and do not imply clinical or therapeutic outcomes.

1. Neurotransmitter associated gene expression profiling

Selank is frequently used in studies that profile gene expression linked to neurotransmitter systems. Researchers apply Selank to neural cell cultures brain slice preparations and in vivo rodent models and then measure transcriptional changes in genes associated with GABAergic monoaminergic and neuropeptide pathways.
Techniques such as quantitative PCR microarrays and RNA sequencing are employed to characterise shifts in expression of receptors transporters enzymes and neurotrophic factors including BDNF. This positions Selank as a probe for mapping peptide sensitive transcriptional programs in central nervous system tissues.

2. GABAergic signaling investigations in neural tissue

A primary focus of Selank research involves components of the GABAergic system. Rodent brain preparations and neuronal cultures are used to examine how Selank exposure influences GABA receptor subunits GABA synthesis and uptake machinery and inhibitory synaptic activity. Electrophysiological recordings receptor binding studies and downstream signaling assays help define how tuftsin derived peptides interface with inhibitory neurotransmission. These experiments are aimed at mechanism discovery rather than clinical application.

3. Enkephalin degrading enzyme activity assays

Selank has been incorporated into biochemical assays that study enkephalin degrading enzymes. In these systems investigators measure enzyme activity in the presence and absence of Selank to evaluate potential modulation of peptidase function. Readouts include substrate turnover kinetics inhibitor sensitivity and changes in peptide fragment profiles. This work supports broader efforts to understand how exogenous peptides may influence endogenous neuropeptide metabolism under defined conditions.

4. Immune related gene transcription and cytokine signaling

Neuroimmune modulation is another key area where Selank is used experimentally. Cell based and animal models are employed to track changes in cytokine and chemokine gene expression particularly markers such as IL 6 and related immune regulators. Researchers expose neural or immune related cells to Selank and inflammatory stimuli and then quantify transcriptional and protein level responses. These designs help clarify how peptide mediated signaling may intersect with immune related pathways in the nervous system.

5. Peptide stability and receptor associated signaling dynamics

Selank is also evaluated from a pharmacologic and signaling kinetics perspective. Studies characterise peptide stability in biological media receptor binding properties and time courses of downstream pathway activation. Assays include receptor engagement testing analysis of intracellular second messengers and monitoring of signaling cascade activation and resolution. These data are used to define concentration response relationships and temporal patterns of action in preclinical settings.

Typical research applications

Across laboratories Selank is commonly used in gene expression profiling for neurotransmitter associated pathways GABAergic signaling studies in rodent neural tissue
biochemical assays of enkephalin degrading enzyme activity immune related transcription studies involving cytokines and chemokines evaluations of peptide stability and receptor linked signaling dynamics. In all these applications Selank functions as a defined research peptide for mechanistic investigation not as a clinical agent.

Important research disclaimer

All findings summarised here arise from in vitro experiments ex vivo preparations and animal models under controlled protocols.They are provided solely to inform qualified researchers about how Selank is used in preclinical studies. These observations do not demonstrate or imply that Selank is safe or effective for any human or veterinary indication. They are not dosing instructions medical advice or guidance for treatment of anxiety mood disorders cognitive issues or any other condition. The Selank product offered is intended strictly for laboratory research applications. It is not for human or veterinary use and must not be used for diagnosis treatment cure prevention or mitigation of any disease or condition.